During a discussion at a New York conference in October, Kevin Chen described a groundbreaking discovery that could be a huge push for innovation within the cannabis industry. It’s called Cellular Agriculture.
Cellular agriculture uses genetic modification to craft products with certain amounts of specified cannabinoids. Also, proponents have been applying this process elsewhere to uncured meats. However, innovators within the cannabis industry are starting to efficiently develop products rich in THC, CBD or other cannabinoids. And they are tailored to treat medical conditions and the recreational market with reliable, consistent ingredients.
The cannabinoid CBDV (cannabidivarin) has particularly received attention recently for its potential to treat patients with epilepsy. However, traditional cannabis farming cannot yield enough CBDV, experts say, but cellular agriculture could.
“There are enough groups working on this now that cellular agriculture is going to have a big role in this industry,” said Chen, president of Hyasynth Bio, a Montreal company that conducts cellular agriculture primarily for medical cannabis product development.